Bruker Corp (NAS:BRKR)
$ 75.07 -0.75 (-0.99%) Market Cap: 10.91 Bil Enterprise Value: 12.03 Bil PE Ratio: 27.30 PB Ratio: 7.71 GF Score: 96/100

Bruker Corp at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 02:50PM GMT
Release Date Price: $43.15 (+0.35%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Hello. Welcome to another morning session at day 2 of the UBS Global Healthcare Conference. I'm Dan Brennan. I cover tools, diagnostics, pharma services. I'm pleased to be joined with me in this virtual meeting with senior management from Bruker Corp. Without any introduction needed, we have Frank Laukien, Chairman, President and CEO; and also on the phone is Miroslava Minkova, who is the Head of IR.

So first off, thank you both for being here. And I think the approach will be, Frank is going to provide some opening remarks for a bit, and then we'll get into Q&A. And anyone dialed into the webcast or going through the computer, please feel free to pose any questions you'd like on the computer and I can see them pop up on my screen. So with no further ado, Frank?

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

Thank you very much, Dan. Thanks for having us on the UBS Virtual Global Healthcare Conference.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot